Psomagen Inc. logo

Psomagen Inc. (950200)

Market Closed
11 Aug, 05:25
KRX SM KRX SM
2,990. 00
+30
+1.0135%
82.14B Market Cap
- P/E Ratio
- Div Yield
8,853 Volume
- Eps
2,960
Previous Close
Add Transaction
Day Range
2,930 3,000
Year Range
2,380 4,665
Want to track 950200 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

950200 closed today higher at ₩2,990, an increase of 1.0135% from yesterday's close, completing a monthly increase of 6.7857% or ₩190. Over the past 12 months, 950200 stock lost -22.9381%.
950200 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on one exchange.

950200 Chart

People also search for

Chin Hung International Holdings Ltd. Preferred Stock
1,360
+5.8366%
Firstec Co., Ltd.
6,460
-0.6154%
Kolon Corporation
13,660
-1.7266%
Young Poong Precision Corp.
12,500
-0.1597%
Geumhwa Psc Co. Ltd.
33,200
+0.6061%

Psomagen Inc. (950200) FAQ

What is the stock price today?

The current price is ₩2,990.00.

On which exchange is it traded?

Psomagen Inc. is listed on KRX SM.

What is its stock symbol?

The ticker symbol is 950200.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 82.14B.

Has Psomagen Inc. ever had a stock split?

No, there has never been a stock split.

Psomagen Inc. Profile

Professional Services Industry
Industrials Sector
- CEO
KRX SM Exchange
- ISIN
United States Country
95 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Psomagen, Inc. is a prestigious entity dedicated to providing comprehensive multi-omics solutions tailored for both clinical and research applications. Originating as Macrogen Corp., the company underwent a significant rebranding to Psomagen, Inc. in April 2019, marking a new chapter in its mission to advance scientific understanding and healthcare. Since its incorporation in 2004, Psomagen has established its headquarters in Rockville, Maryland, where it continues to innovate at the intersection of biology and technology. With a rich heritage in genomics and a forward-looking approach, Psomagen, Inc. is at the forefront of decoding the complexities of life, offering invaluable insights into the genetic, epigenetic, and proteomic intricacies that define living organisms.

Products and Services

Genomics: Delving into the fundamentals of genetic information, Psomagen offers comprehensive analyses of gene sequences and expressions. This service is instrumental in understanding the genetic blueprint of organisms, providing vital insights into hereditary conditions, evolutionary biology, and personalized medicine.

Epigenomics: Psomagen's epigenomics services shed light on the critical, yet often overlooked, layer of genetic regulation. By examining chromatin assembly, histone modifications, and DNA-protein interactions, researchers can uncover the epigenetic mechanisms that influence gene expression and contribute to complex traits and diseases.

Metagenomics: Exploring the genetic material derived from entire communities of microorganisms, Psomagen’s metagenomics services offer a window into the microbial world. This analysis is crucial for understanding microbial diversity, ecosystem functions, and the roles of microbes in health and disease.

Transcriptomics: Focusing on RNA and its myriad forms, Psomagen provides transcriptomics services to analyze gene expression levels across different conditions. This critical analysis can reveal the dynamic nature of gene expression, offering insights into developmental processes, disease mechanisms, and responses to environmental changes.

Proteomics: By studying the entire set of proteins produced in an organism, Psomagen's proteomics services illuminate the functional outcomes of gene expression. This comprehensive analysis aids in understanding the complexities of biological systems, identifying biomarkers, and revealing potential therapeutic targets.

Bioinformatics: Beyond the generation of biological data, Psomagen offers advanced bioinformatics solutions. These software tools and pipelines are essential for analyzing complex datasets, enabling scientists to extract meaningful insights from their research. Whether for genomics, epigenomics, or any of the omics sciences, Psomagen’s bioinformatics services turn data into knowledge.

Clinical Testing Solutions: Complementing its research services, Psomagen also provides clinical testing solutions that support the diagnosis and management of diseases. These solutions leverage the company's omics and bioinformatics expertise to offer accurate, reliable, and actionable information for healthcare professionals and patients alike.

Contact Information

Address: 1330 Piccard Drive
Phone: 301 251 1007